You can access the distribution details by navigating to My pre-printed books > Distribution

Add a Review

An introduction to Drug Regulatory Affairs (eBook)

Introduction to Drug Regulatory Affairs
Type: e-book
Genre: Medicine & Science
Language: English
Price: ₹399
(Immediate Access on Full Payment)
Available Formats: PDF


Regulatory Affairs is actively involved in every stage of development of new medicine and the post-marketing activities with authorized medicinal products. Introduction to Drug Regulatory affairs book is aimed at health care professionals including Pharma students, students of the professions allied to science and medicine. The chapters of the books provide an overview of introduction to regulatory affairs field, information of different regulatory authorities, how these professional works, different roles, and responsibilities of regulatory affairs professional.
This book also gives information about different skills required for regulatory affairs career and employment opportunities exits in various sectors.
Mrs. Sucheta Patil

Consultant, Regulatory affairs. Contact no. 7387954835

About the Author

Mrs Sucheta Ligade is working as Regulatory consultant in Top MNC in India. She has more than 5 years of experience in drug application and development process. Also she consult various pharma organization to develop their own regulatory department

Book Details

Publisher: Sucheta Ligade
Number of Pages: 44
Availability: Available for Download (e-book)

Ratings & Reviews

An introduction to Drug Regulatory Affairs

An introduction to Drug Regulatory Affairs

(Not Available)

Review This Book

Write your thoughts about this book.

Currently there are no reviews available for this book.

Be the first one to write a review for the book An introduction to Drug Regulatory Affairs.

Other Books in Medicine & Science

Shop with confidence

Safe and secured checkout, payments powered by Razorpay. Pay with Credit/Debit Cards, Net Banking, Wallets, UPI or via bank account transfer and Cheque/DD. Payment Option FAQs.